Literature DB >> 9167527

Cyproheptadine: a potent in vivo serotonin antagonist.

S Kapur, R B Zipursky, C Jones, A A Wilson, J D DaSilva, S Houle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9167527     DOI： 10.1176/ajp.154.6.884a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Unexpected remission of hepatocellular carcinoma (HCC) with lung metastasis to the combination therapy of thalidomide and cyproheptadine: report of two cases and a preliminary HCC cell line study.

Authors:  Yu-Min Feng; Chin-Wen Feng; Solomon Chih-Cheng Chen; Cheng-Da Hsu
Journal:  BMJ Case Rep       Date:  2012-10-12

Review 2.  Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system.

Authors:  Michelle A Patriquin; Isabelle E Bauer; Jair C Soares; David P Graham; David A Nielsen
Journal:  Psychiatr Genet       Date:  2015-10       Impact factor: 2.458

3.  Linezolid-induced serotonin syndrome.

Authors:  Vishal Gupta; Niteen D Karnik; Rushikesh Deshpande; Meenakshi Amit Patil
Journal:  BMJ Case Rep       Date:  2013-03-18

4.  Concurrent Serotonin Syndrome and Prolong QT Interval Induced by Paroxetine Overdose With Isotretinoin.

Authors:  Omar Al-Radideh; Kok Hoe Chan; Shawn Gupta; Jihad Slim; Sharath Bellary
Journal:  Cureus       Date:  2021-04-15

5.  Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose.

Authors:  Kimberly Little; Christine M Lin; Paul M Reynolds
Journal:  Am J Case Rep       Date:  2018-05-25

Review 6.  Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity.

Authors:  Florian Eyer; Thomas Zilker
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.